相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。112PCombination effects of MEK inhibitors with statins on cancer cells
M Iizuka-Ohashi et al.
ANNALS OF ONCOLOGY (2018)
RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis
M. Lee Schmidt et al.
CANCER RESEARCH (2018)
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations
Lauretta Odogwu et al.
ONCOLOGIST (2018)
Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity
Elaine Lai Han Leung et al.
CELL DEATH & DISEASE (2018)
Mutant KRAS promotes malignant pleural effusion formation
Theodora Agalioti et al.
NATURE COMMUNICATIONS (2017)
Survival of pancreatic cancer cells lacking KRAS function
Mandar Deepak Muzumdar et al.
NATURE COMMUNICATIONS (2017)
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Nirakar Rajbhandari et al.
CELL REPORTS (2017)
The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin
Kana T. Furukawa et al.
CELL REPORTS (2017)
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
Sai Krishna Athuluri-Divakar et al.
CELL (2016)
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling
Ralph Gruber et al.
GASTROENTEROLOGY (2016)
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
Piro Lito et al.
SCIENCE (2016)
Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic
Benjamin D. Levine et al.
CELL REPORTS (2016)
Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients
Jara M. Baas et al.
ANTI-CANCER DRUGS (2015)
Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
J. M. Baas et al.
INVESTIGATIONAL NEW DRUGS (2015)
IQGAPs choreograph cellular signaling from the membrane to the nucleus
Jessica M. Smith et al.
TRENDS IN CELL BIOLOGY (2015)
IQGAP1 selectively interacts with K-Ras but not with H-Ras and modulates K-Ras function
Hironori Matsunaga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors
Piro Lito et al.
CANCER CELL (2014)
Small GTPase RBJ Mediates Nuclear Entrapment of MEK1/MEK2 in Tumor Progression
Taoyong Chen et al.
CANCER CELL (2014)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor et al.
CELL (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
Weiying Zhang et al.
SCIENCE SIGNALING (2014)
MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer
Lanlan Li et al.
FEBS LETTERS (2013)
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann et al.
NATURE (2013)
IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors
Katherine L. Jameson et al.
NATURE MEDICINE (2013)
Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation
Stephanie Duhamel et al.
CANCER RESEARCH (2012)
Mutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras
David Matallanas et al.
MOLECULAR CELL (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase
Chen-Ying Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development
Deborah K. Morrison
TRENDS IN CELL BIOLOGY (2009)
Identification and characterization of a general nuclear translocation signal in signaling proteins
Dana Chuderland et al.
MOLECULAR CELL (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling
Nicolas Dumaz et al.
CANCER RESEARCH (2006)
IQGAP1 is a scaffold for mitogen-activated protein kinase signaling
M Roy et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The many faces of β-TrCP E3 ubiquitin ligases:: reflections in the magic mirror of cancer
SY Fuchs et al.
ONCOGENE (2004)
Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis
JH Wu et al.
CANCER RESEARCH (2004)
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
JF Ohren et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer
MR Graaf et al.
CANCER TREATMENT REVIEWS (2004)
The dark side of Ras: regulation of apoptosis
AD Cox et al.
ONCOGENE (2003)
Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1
Z Yao et al.
ONCOGENE (2001)
Mammalian MAP kinase signalling cascades
LF Chang et al.
NATURE (2001)
分享论文
